Detalhe da pesquisa
1.
Greater than 95% success with 14-day bismuth quadruple anti- Helicobacter pylori therapy: a pilot study in US Hispanics.
Helicobacter;
17(5): 382-90, 2012 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22967122